Experience Ibogaine Treatment Center

What Experience Ibogaine Treatment Center does

Experience Ibogaine Treatment Center is a private medical facility specializing in ibogaine hydrochloride and 5-MeO-DMT-assisted psychedelic therapy for substance use disorders and mental health conditions. Founded circa 2013 in Tijuana, Mexico, and operated through the Colorado-registered LLC Experience Life Sciences, LLC (with a US corporate office in Denver), the center delivers structured 5-to-12-day treatment programs (and 1-2 month Suboxone detox protocols) covering opioid, fentanyl, methamphetamine, cocaine, alcohol, and poly-substance dependencies, plus PTSD, depression, anxiety, and traumatic brain injury. Core technical components include standardized ibogaine HCl sourced from a South African laboratory, 5-MeO-DMT integration sessions, 24/7 medical supervision, and pre/post-treatment counseling using CBT, DBT, and mindfulness modalities. The company reports treating 3,000+ patients over 13 years with a claimed 99% initial detox completion rate.

The business model is direct-to-consumer, cash-pay, and quote-based: prospective US patients initiate contact through an online application or toll-free 1-800 number, complete a free consultation, and then travel to the Tijuana facility (with concierge airport pickup from San Diego). Pricing is not publicly disclosed but the company positions itself at approximately half the price of comparable ibogaine facilities, with percentage-based discounts for military veterans and first responders. Revenue is generated entirely through one-time treatment program fees, with no subscription, insurance billing, or enterprise contracting. Go-to-market relies on organic SEO across 70+ US city/state landing pages, Google reviews and patient testimonials, PR placements in Wired, WSMV, and WBUR, podcast and video content, and word-of-mouth referrals within psychedelic recovery communities. The company participates in the Ohio State University Ibogaine Patient Study, supplying self-reported patient data to advance clinical research.

The clinic is owned and operated by Aeden and Valeria, who function as both founders and direct patient-facing sales/consultation staff. The company has no disclosed institutional investors, funding rounds, M&A activity, or parent organization. Customer concentration is structurally low, as the entire base consists of individual cash-pay consumers distributed across multiple substance dependencies and US geographies. The principal growth levers visible in the data are SEO and PR-driven US demand generation, dedicated veteran/first-responder discount programs, and a recently expanded post-treatment aftercare offering announced in late 2025.

Name

Experience Ibogaine Treatment Center

Legal name

Experience Life Sciences, LLC

Website

https://experienceibogaine.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

Experience Ibogaine Treatment Center is a Tijuana-based private clinic, operated by Colorado-registered Experience Life Sciences, LLC, that delivers ibogaine and 5-MeO-DMT psychedelic therapy programs for US patients with opioid, alcohol, stimulant, and poly-substance addictions plus PTSD and depression. It runs 5-to-12-day cash-pay protocols and has treated 3,000+ patients over 13 years.

Ownership category

akta.pro rank

Product category

Addiction Treatment Services

NAICS

Residential Mental Health and Substance Abuse Facilities (623220), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Health Services (8000), Services-Nursing & Personal Care Facilities (8050)

akta.pro primary industry

Residential Substance Use Rehabilitation (Inpatient Rehab) (HLAFACAE)

akta.pro secondary industries

Substance Use Detoxification Centers (Medical Detox) (HLAFACAD), Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

Keywords

• Ibogaine treatment programs
• Addiction detox services
• Psychedelic assisted therapy
• Opioid withdrawal treatment
• 5-MeO-DMT integration

Headquarters

HQ city

Tijuana

HQ country

Mexico

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Treatment Program Fees: Experience Ibogaine generates revenue through fees charged for its ibogaine and 5-MeO-DMT treatment programs. Programs vary in duration from 5 to 12+ days and include ibogaine dosing, medical supervision, therapy, meals, accommodations, and aftercare. The company positions itself as affordable compared to competitors, offering half the price of comparable treatment options. Pricing is quote-based and not publicly disclosed on the website.
2. Specialized Population Premium Programs: Dedicated treatment programs for specific populations including first responders (police officers, firefighters, paramedics, EMTs) and military veterans, with discounted rates offered to these groups as a percentage-based reduction from standard pricing.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Experience Ibogaine Treatment Center delivers medically supervised, ibogaine hydrochloride-based detoxification and psychedelic-assisted therapy programs at its Tijuana, Mexico clinic, primarily serving US residents with opioid, alcohol, stimulant, and poly-substance dependencies as well as PTSD, depression, anxiety, and traumatic brain injury. Programs range from 5-day short-acting opiate detoxes to 12-day full detoxes and 1-2 month long-acting opiate (Suboxone/Methadone) protocols, each combining ibogaine HCl dosing with 5-MeO-DMT capstone sessions, CBT/DBT/mindfulness counseling, and structured aftercare. Revenue is earned through one-time program fees rather than subscriptions, with discounts available for military veterans and first responders.

Product overview

Experience Ibogaine Treatment Center offers a suite of specialized ibogaine-based treatment programs for addiction recovery and mental health conditions. The core offering consists of time-based detox programs (5-day, 12-day, and 1-2 month durations) tailored to specific substance dependencies (opiates, Fentanyl, Suboxone, methamphetamine, cocaine, alcohol) and conditions (PTSD, depression). Each program integrates Ibogaine Hydrochloride Treatment with 5-MeO-DMT sessions and comprehensive therapeutic support including pre/post-treatment counseling. The center also provides extended aftercare programs with follow-up integration sessions, and partners with Ohio State University for ongoing clinical research.

Differentiator

Problem solved

Functional benefit

Products and services

• 5-Day Opiate Detox

Quantifiable outcome

• 99% detox completion rate for the initial detox phase
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Ohio State UniversitycoreStrategic or Co-development PartnerExperience Ibogaine participates in the Ohio State University Ibogaine Patient Study, a research initiative that collects self-reported data from ibogaine treatment patients. Patients complete intake surveys and ongoing assessments, with their anonymized data shared with researchers and health authority regulators to advance understanding of ibogaine and support potential clinical trial approvals. The company also previously supported a University of Alabama ibogaine study, indicating a commitment to evidence-based research.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ibogaine by David Dardashti: Long-running ibogaine treatment facilitator connecting US patients with Mexico-based clinics. Represents a comparable booking/facilitation-plus-treatment model competing for the same US clientele.
• Crossroads Treatment Center: Mexico-based residential ibogaine and addiction treatment facility. Direct competitor offering comparable inpatient substance use programs to US patients.
• New Roots Ibogaine: Ibogaine treatment provider for substance use disorders, operating in Mexico. Offers directly comparable protocols and competes for the same US patient market.
• Beond Ibogaine: Mexico-based ibogaine clinic offering residential addiction treatment programs targeting US patients. Operates a similar medical-tourism model with intensive ibogaine dosing protocols and aftercare support.
• Clear Sky Recovery: Ibogaine treatment center based in Cancun, Mexico, treating US patients for opioid and substance use disorders. Same medical-tourism model with comparable 5-12 day programs and ibogaine HCl-based protocols targeting the same US customer base.
• rebooted (St. Kitts Ibogaine): Caribbean-based ibogaine treatment center offering residential programs. Comparable service model targeting US clients seeking regulated, sub-acute ibogaine treatment abroad.
• Ambio Life Sciences (formerly Pangea Biomedics): Mexico-based ibogaine and addiction treatment provider. Sibling operator in the same Tijuana-region medical-tourism segment, offering residential ibogaine programs for opioid and polysubstance dependence.
• The Holistic Sanctuary: Sedona-based alternative addiction treatment provider using plant-based and psychedelic modalities. Targets a similar high-end private-pay clientele seeking non-traditional detox options.

Broad incumbents

• Compass Pathways: Public clinical-stage psychedelic therapy company developing psilocybin treatment for treatment-resistant depression. Operates in the broader psychedelic therapy category and represents a regulated, well-capitalized incumbent moving toward FDA approval.
• Field Trip Health & Wellness (now Mindset Pharma peer): Psychedelic therapy clinic operator ( ketamine-assisted therapy ). Comparable service model in the psychedelic mental-health treatment category, but operating in regulated jurisdictions (US/Canada) and not focused on ibogaine.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/experienceiboga
• LinkedInlinkedin.com/company/experience-ibogaine-treatment-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Experience Ibogaine Treatment Center